BASSI, Cristian
 Distribuzione geografica
Continente #
NA - Nord America 4.192
AS - Asia 2.068
EU - Europa 1.585
SA - Sud America 275
Continente sconosciuto - Info sul continente non disponibili 114
AF - Africa 44
OC - Oceania 2
Totale 8.280
Nazione #
US - Stati Uniti d'America 4.052
SG - Singapore 752
CN - Cina 469
IT - Italia 447
DE - Germania 273
VN - Vietnam 251
BR - Brasile 205
PL - Polonia 202
FI - Finlandia 164
HK - Hong Kong 137
BD - Bangladesh 128
GB - Regno Unito 126
TR - Turchia 91
CA - Canada 79
UA - Ucraina 67
SE - Svezia 62
FR - Francia 58
JP - Giappone 47
ID - Indonesia 46
MX - Messico 46
IN - India 40
RU - Federazione Russa 35
AR - Argentina 29
BE - Belgio 29
NL - Olanda 29
ES - Italia 20
IQ - Iraq 16
AT - Austria 14
LT - Lituania 13
ZA - Sudafrica 13
UZ - Uzbekistan 11
PK - Pakistan 10
CO - Colombia 9
CZ - Repubblica Ceca 9
EG - Egitto 9
IE - Irlanda 9
TN - Tunisia 9
EC - Ecuador 8
SA - Arabia Saudita 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
KR - Corea 7
BO - Bolivia 5
CH - Svizzera 5
CL - Cile 5
JO - Giordania 5
PH - Filippine 5
AL - Albania 4
DZ - Algeria 4
IR - Iran 4
JM - Giamaica 4
KZ - Kazakistan 4
LV - Lettonia 4
MY - Malesia 4
ET - Etiopia 3
HU - Ungheria 3
NP - Nepal 3
OM - Oman 3
PE - Perù 3
TW - Taiwan 3
AU - Australia 2
GR - Grecia 2
HN - Honduras 2
IL - Israele 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LK - Sri Lanka 2
MA - Marocco 2
PY - Paraguay 2
QA - Qatar 2
RO - Romania 2
TT - Trinidad e Tobago 2
BG - Bulgaria 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GD - Grenada 1
GP - Guadalupe 1
GY - Guiana 1
KH - Cambogia 1
KW - Kuwait 1
KY - Cayman, isole 1
LU - Lussemburgo 1
MQ - Martinica 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PS - Palestinian Territory 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TL - Timor Orientale 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.167
Città #
Ashburn 575
Singapore 457
San Jose 338
Fairfield 328
Woodbridge 267
Warsaw 202
Beijing 192
Chandler 171
Munich 171
Ann Arbor 160
Houston 157
Santa Clara 155
Ferrara 146
Seattle 137
Hong Kong 132
New York 115
Wilmington 109
Cambridge 108
Dallas 107
Helsinki 98
Los Angeles 89
Council Bluffs 86
Ho Chi Minh City 86
Jacksonville 80
Milan 58
Hanoi 51
Tokyo 46
Turku 44
Izmir 42
Jakarta 41
Shanghai 39
Nanjing 33
Lauterbourg 30
Brussels 29
Princeton 29
Mexico City 27
Orem 27
Boardman 25
San Diego 25
Toronto 25
London 24
Chicago 23
Montreal 22
Buffalo 21
Rome 21
Phoenix 20
São Paulo 19
Bologna 17
Denver 17
Addison 16
Atlanta 16
Bremen 16
Brooklyn 16
Dong Ket 15
Tianjin 15
Turin 15
Frankfurt am Main 14
Da Nang 13
The Dalles 13
Amsterdam 12
Chennai 12
Washington 12
Nuremberg 11
Poplar 10
Shenyang 10
Stockholm 10
Charlotte 9
Dublin 9
Falls Church 9
Mountain View 9
Nanchang 9
Redwood City 9
San Francisco 9
Barnet 8
Johannesburg 8
Rio de Janeiro 8
Salt Lake City 8
Tashkent 8
Vancouver 8
Boston 7
Changsha 7
Hangzhou 7
Hebei 7
Manchester 7
Ankara 6
Baghdad 6
Gangnam-gu 6
Haiphong 6
Kyiv 6
Monte San Pietro 6
Moscow 6
Secaucus 6
Vienna 6
Amman 5
Belo Horizonte 5
Biên Hòa 5
Brno 5
Bến Tre 5
Cairo 5
City of London 5
Totale 5.682
Nome #
Absolute quantification of cell-free microRNAs in cancer patients 339
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma 319
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 316
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 308
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy 305
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 304
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 302
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 281
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 276
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 274
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 269
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 268
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 255
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 251
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 247
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 241
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 240
HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights 236
Defining the oral microbiome by whole-genome sequencing and resistome analysis: The complexity of the healthy picture 231
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 227
Estrogen receptor mutation: a new strategy to overcome endocrine resistance 219
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model 208
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer 197
Circulating microRNAs as biomarkers for stratifying different phases of liver cancer progression and response to therapy 196
Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study 192
Airborne Microbial Investigation in Operating Rooms Using MALDI-TOF and Next-Generation Sequencing (NGS) to Reduce Surgical Site Infection Risk 178
Detection of disease-causing mutations in prostate cancer by NGS sequencing 175
DNA methylation of shelf, shore and open sea CpG positions distinguish high microsatellite instability from low or stable microsatellite status colon cancer stem cells 173
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 173
Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients 172
Interspecies gene name extrapolation - A new approach 157
Novel Virus Identification through Metagenomics: A Systematic Review 153
Microbiota and environmental health monitoring of mouse colonies by metagenomic shotgun sequencing 144
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 133
null 89
Unraveling the role of microRNA/isomiR network in multiple primary melanoma pathogenesis 85
Preliminary results from whole-genome expression analysis in patients with secondary adrenal insufficiency treated with modified-release hydrocortisone 71
Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer 69
Intraoperative Airborne Contamination in Operating Rooms: A Multiparametric Analysis Integrating Culture‐Based Microbiology, Metagenomic Sequencing, Particle Counts, and Procedural Determinants 7
Totale 8.280
Categoria #
all - tutte 35.829
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.829


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022344 0 22 31 12 21 19 38 17 12 31 41 100
2022/2023398 35 40 24 53 54 61 39 24 35 6 17 10
2023/2024286 17 25 17 8 35 76 13 12 4 8 6 65
2024/20251.439 27 26 86 69 129 157 90 63 281 126 186 199
2025/20263.412 352 133 239 362 458 218 451 211 341 319 245 83
2026/2027222 83 139 0 0 0 0 0 0 0 0 0 0
Totale 8.280